Screening for prostate cancer - Randomised trials of treatment in early disease are important

被引：0
|
作者：
Harwood, RH
机构：
来源：
BMJ-BRITISH MEDICAL JOURNAL | 1997年 / 315卷 / 7101期
关键词：
D O I：
10.1136/bmj.315.7101.186b
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：186 / 187
页数：2
相关论文
共 50 条
  • [1] Screening for prostate cancer - Early screening is important despite lack of data from trials
    Catalona, WJ
    BRITISH MEDICAL JOURNAL, 1997, 315 (7101): : 187 - 187
  • [2] Rationale for randomised trials of prostate cancer screening
    Alexander, FE
    Andriole, GL
    Aus, G
    Auvinen, A
    Beensterboer, P
    Blijenberg, BG
    Bonardi, R
    Buys, S
    Candas, B
    Ciatto, S
    Crawford, ED
    Demers, R
    de Koning, HJ
    Denis, L
    Dijk, MA
    Figueiredo, F
    Gellman, EP
    Gohagan, J
    Hakama, M
    Hugosson, J
    Kirkels, WI
    Kranse, R
    van der Kwast, TH
    Lilja, H
    Määttänen, L
    Mandel, J
    Miller, AB
    Monteiro, H
    Nelen, V
    Oberman, A
    Paez, A
    Prorok, PC
    Reding, D
    Rietbergen, JWBW
    Rose, DB
    Sanchez, AB
    Schröder, FH
    da Silva, EC
    Simpson, N
    Smith, PH
    Stadaert, B
    Stenman, UH
    Teppo, L
    Turkes, A
    Weissfeld, JL
    Yokochi, L
    EUROPEAN JOURNAL OF CANCER, 1999, 35 (02) : 262 - 271
  • [3] Is prostate cancer screening responsible for the negative results of prostate cancer treatment trials?
    Prasad, Vinay
    MEDICAL HYPOTHESES, 2016, 93 : 71 - 73
  • [4] Shared decision-making for prostate cancer screening and treatment: a systematic review of randomised controlled trials
    Anani, Martinez-Gonzalez Nahara
    Andreas, Plate
    Oliver, Senn
    Stefan, Markun
    Thomas, Rosemann
    Stefan, Neuner-Jehle
    SWISS MEDICAL WEEKLY, 2018, 148
  • [5] Measurement of prostate specific antigen as screening test for prostate cancer - Trials of treatment are needed before trials of screening
    Sandhu, S
    Morris, R
    Matveev, V
    Kaisary, AV
    BRITISH MEDICAL JOURNAL, 1996, 312 (7032): : 709 - 709
  • [6] Prostate cancer screening: what can we learn from randomised trials?
    Auvinen, Anssi
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 (01) : 12 - 17
  • [7] Does screening for prostate cancer identify clinically important disease?
    Feneley, MR
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 1999, 81 (03) : 207 - 214
  • [8] Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials
    Lebeau, Jean-Pierre
    Pouchain, Denis
    EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2010, 21 (94): : 155 - 156
  • [9] Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials
    Djulbegovic, Mia
    Beyth, Rebecca J.
    Neuberger, Molly M.
    Stoffs, Taryn L.
    Vieweg, Johannes
    Djulbegovic, Benjamin
    Dahm, Philipp
    BMJ-BRITISH MEDICAL JOURNAL, 2010, 341 : 593
  • [10] Should we start population screening for prostate cancer? Randomised trials are still needed
    Auvinen, A
    Alexander, FE
    de Koning, HJ
    Miller, AB
    INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (03) : 377 - 378
12345